Oak Hill Wealth Advisors, LLC Halozyme Therapeutics, Inc. Transaction History
Oak Hill Wealth Advisors, LLC
- $406 Billion
- Q3 2024
A detailed history of Oak Hill Wealth Advisors, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Oak Hill Wealth Advisors, LLC holds 10,800 shares of HALO stock, worth $659,772. This represents 0.15% of its overall portfolio holdings.
Number of Shares
10,800
Previous 10,800
-0.0%
Holding current value
$659,772
Previous $565 Million
9.32%
% of portfolio
0.15%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding HALO
# of Institutions
522Shares Held
123MCall Options Held
208KPut Options Held
77.1K-
Black Rock Inc. New York, NY17.6MShares$1.08 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$787 Million0.01% of portfolio
-
State Street Corp Boston, MA5.81MShares$355 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.04MShares$247 Million4.92% of portfolio
-
Alliancebernstein L.P. New York, NY3.55MShares$217 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.51B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...